SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-215473
Filing Date
2019-08-07
Accepted
2019-08-07 17:06:32
Documents
6
Effectiveness Date
2019-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d760381ds8.htm S-8 71432
2 EX-5.1 d760381dex51.htm EX-5.1 8974
3 EX-23.2 d760381dex232.htm EX-23.2 1676
4 GRAPHIC g760381g32w78.jpg GRAPHIC 2243
5 GRAPHIC g760381g35z41.jpg GRAPHIC 2693
6 GRAPHIC g760381g84j14.jpg GRAPHIC 8136
  Complete submission text file 0001193125-19-215473.txt   101529
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233094 | Film No.: 191006360
SIC: 2834 Pharmaceutical Preparations